170 related articles for article (PubMed ID: 15475833)
1. Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.
Wolfrum S; Dendorfer A; Schutt M; Weidtmann B; Heep A; Tempel K; Klein HH; Dominiak P; Richardt G
J Cardiovasc Pharmacol; 2004 Sep; 44(3):348-55. PubMed ID: 15475833
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation.
Gao F; Gao E; Yue TL; Ohlstein EH; Lopez BL; Christopher TA; Ma XL
Circulation; 2002 Mar; 105(12):1497-502. PubMed ID: 11914261
[TBL] [Abstract][Full Text] [Related]
3. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
[TBL] [Abstract][Full Text] [Related]
4. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
Hamid SA; Bower HS; Baxter GF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.
Yasuda S; Kobayashi H; Iwasa M; Kawamura I; Sumi S; Narentuoya B; Yamaki T; Ushikoshi H; Nishigaki K; Nagashima K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1558-65. PubMed ID: 19286954
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.
Bell RM; Yellon DM
J Mol Cell Cardiol; 2003 Feb; 35(2):185-93. PubMed ID: 12606259
[TBL] [Abstract][Full Text] [Related]
7. The activation of PI 3-kinase/Akt pathway is involved in the acute effects of simvastatin against ischaemia and reperfusion-induced arrhythmias in anaesthetised dogs.
Kisvári G; Kovács M; Seprényi G; Végh Á
Eur J Pharmacol; 2015 Dec; 769():185-94. PubMed ID: 26597117
[TBL] [Abstract][Full Text] [Related]
8. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway.
Tsang A; Hausenloy DJ; Mocanu MM; Yellon DM
Circ Res; 2004 Aug; 95(3):230-2. PubMed ID: 15242972
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Rho-kinase by fasudil restores the cardioprotection of ischemic postconditioninng in hypercholesterolemic rat heart.
Wu N; Li W; Shu W; Lv Y; Jia D
Mol Med Rep; 2014 Nov; 10(5):2517-24. PubMed ID: 25231456
[TBL] [Abstract][Full Text] [Related]
10. Postconditioning effect of granulocyte colony-stimulating factor is mediated through activation of risk pathway and opening of the mitochondrial KATP channels.
Sumi S; Kobayashi H; Yasuda S; Iwasa M; Yamaki T; Yamada Y; Ushikoshi H; Hattori A; Aoyama T; Nishigaki K; Takemura G; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1174-82. PubMed ID: 20693399
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 90 transfection reduces ischemia-reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation.
Kupatt C; Dessy C; Hinkel R; Raake P; Daneau G; Bouzin C; Boekstegers P; Feron O
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1435-41. PubMed ID: 15178564
[TBL] [Abstract][Full Text] [Related]
12. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO.
Yang XM; Krieg T; Cui L; Downey JM; Cohen MV
J Mol Cell Cardiol; 2004 Mar; 36(3):411-21. PubMed ID: 15010280
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway.
Okumura H; Nagaya N; Itoh T; Okano I; Hino J; Mori K; Tsukamoto Y; Ishibashi-Ueda H; Miwa S; Tambara K; Toyokuni S; Yutani C; Kangawa K
Circulation; 2004 Jan; 109(2):242-8. PubMed ID: 14691041
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts.
Di Napoli P; Antonio Taccardi A; Grilli A; Spina R; Felaco M; Barsotti A; De Caterina R
Cardiovasc Res; 2001 Aug; 51(2):283-93. PubMed ID: 11470468
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
[TBL] [Abstract][Full Text] [Related]
16. U50,488H postconditioning reduces apoptosis after myocardial ischemia and reperfusion.
Tong G; Sun Z; Wei X; Gu C; Kaye AD; Wang Y; Li J; Zhang Q; Guo H; Yu S; Yi D; Pei J
Life Sci; 2011 Jan; 88(1-2):31-8. PubMed ID: 21034750
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning.
Wang Y; Ahmad N; Kudo M; Ashraf M
Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1125-31. PubMed ID: 15142844
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of picroside II on myocardial ischemia reperfusion injury in rats.
Wu N; Li W; Shu W; Jia D
Drug Des Devel Ther; 2014; 8():545-54. PubMed ID: 24868147
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects.
Stirone C; Boroujerdi A; Duckles SP; Krause DN
Mol Pharmacol; 2005 Jan; 67(1):105-13. PubMed ID: 15496504
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.
Ferro A; Coash M; Yamamoto T; Rob J; Ji Y; Queen L
Br J Pharmacol; 2004 Oct; 143(3):397-403. PubMed ID: 15351777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
